MedTrace Logo

Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome

NCT00819923 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 825

Last updated 2011-05-05

No results posted yet for this study

Summary

The purpose of the trial is to compare the safety and effectiveness of bio-active-stent (BAS) and everolimus-eluting stent (EES) in patients presenting with acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

Percutaneous coronary intervention

Intra-coronary stenting

DEVICE

Percutaneous coronary intervention

Intra-coronary stenting

Sponsors & Collaborators

  • The Hospital District of Satakunta

    lead OTHER

Principal Investigators

  • Pasi P Karjalainen, MD, PhD · Satakunta Central Hospital, Pori, Finland

  • Antti Ylitalo, MD, PhD · Satakunta Central Hospital, Pori, Finland

  • Matti Niemela, MD, PhD · Oulu University Hospital

  • Juhani KE Airaksinen, Professor · Turku University Hospital, Turku, Finland

  • Otto Hess, Professor · Bern University Hospital, Bern, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2013-05-31
Completion
2014-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00819923 on ClinicalTrials.gov